An experimental treatment involving stem cells from umbilical cords could significantly reduce deaths and quicken recovery time for patients suffering the most severe form of Covid-19, a study suggests.
US researchers reported a 91 per cent survival rate in seriously ill patients given the stem cell infusion, compared to 42 per cent in a second group who did not receive the treatment.
The adult stem cells Nova Cells uses include umbilical cord (Mesenchymals and others), Wharton’s Jelly, placenta-derived, and a patient’s own bone marrow.
LAB PRIMED STEM CELLS. DONOR IMMUNE CELLS FOR CANCER. STEM CELL HOMING BEACON FACTOR. +1-562-916-3410. 